Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
How should health-related quality of life be assessed in patients with COPD?
Autore:
Mahler, DA;
Indirizzi:
Dartmouth Coll, Hitchcock Med Ctr, Pulm & Crit Care Med Sect, Dartmouth Med Sch, Lebanon, NH 03756 USA Dartmouth Coll Lebanon NH USA 03756 tmouth Med Sch, Lebanon, NH 03756 USA
Titolo Testata:
CHEST
fascicolo: 2, volume: 117, anno: 2000, supplemento:, S
pagine: 54 - 57
SICI:
0012-3692(200002)117:2<54:HSHQOL>2.0.ZU;2-2
Fonte:
ISI
Lingua:
ENG
Soggetto:
OBSTRUCTIVE PULMONARY-DISEASE; AIR-FLOW LIMITATION; OF-LIFE; LUNG-DISEASE; QUESTIONNAIRE; THEOPHYLLINE; DYSPNEA; IMPACT;
Keywords:
bronchodilator therapy; disease-specific instrument; dyspnea; generic health measure; minimum clinically significant change;
Tipo documento:
Article
Natura:
Periodico
Settore Disciplinare:
Clinical Medicine
Life Sciences
Citazioni:
25
Recensione:
Indirizzi per estratti:
Indirizzo: Mahler, DA Dartmouth Coll, Hitchcock Med Ctr, Pulm & Crit Care Med Sect, Dartmouth Med Sch, 1 Med Ctr Dr, Lebanon, NH 03756 USA Dartmouth Coll 1 Med Ctr Dr Lebanon NH USA 03756 , NH 03756 USA
Citazione:
D.A. Mahler, "How should health-related quality of life be assessed in patients with COPD?", CHEST, 117(2), 2000, pp. 54-57

Abstract

The traditional approach of caring for patients with chronic respiratory disease has been to rely on pulmonary function tests to quantify the severity and to assess response to therapy. However, patients with respiratory conditions seek medical attention because of symptoms, particularly dyspnea, and impaired ability to function, which dearly impact on an individual's health-related qualify of life (HRQOL). Accordingly, instruments have been developed to provide a standardized method to measure health status and levelsof impairment. One of the major reasons for measuring HRQOL is to detect how much HRQOL has changed in response to therapy (an evaluative instrument). A minimum clinically significant change has been established for some HRQOL instruments in order to indicate the relative value of any measured change and to guide the interpretation as to whether the change is "clinically meaningful. " Selected studies using disease-specific instruments have demonstrated that beta(2)-agonist, anticholinergic, and theophylline medicationscan improve HRQOL, as compared with placebo therapy.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 05/07/20 alle ore 03:58:25